Generation of homozygous PRKN, PINK1 and double PINK1/PRKN knockout cell lines from healthy induced pluripotent stem cells using CRISPR/Cas9 editing

被引:9
作者
Chen, Carol X. -Q. [1 ]
You, Zhipeng [1 ]
Abdian, Narges [1 ]
Sirois, Julien [1 ]
Shlaifer, Irina [1 ]
Tabatabaei, Mahdieh [2 ]
Boivin, Marie-Noelle [2 ]
Gaborieau, Lydiane [2 ]
Karamchandani, Jason [2 ]
Beitel, Lenore K. [1 ]
Fon, Edward A. [3 ,4 ]
Durcan, Thomas M. [1 ]
机构
[1] McGill Univ, Neuros Early Drug Discovery Unit EDDU, 3801 Univ St, Montreal, PQ H3A 2B4, Canada
[2] McGill Univ, C BIG Repository C BIG, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada
[3] Montreal Neurol Inst, Dept Neurol & Neurosurg, McGill Parkinson Program, Montreal, PQ H3A 2B4, Canada
[4] Montreal Neurol Inst, Dept Neurol & Neurosurg, Neurodegenerat Dis Grp, Montreal, PQ H3A 2B4, Canada
关键词
D O I
10.1016/j.scr.2022.102806
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Autosomal recessive mutations in either PRKN or PINK1 are associated with early-onset Parkinson's disease. The corresponding proteins, PRKN, an E3 ubiquitin ligase, and the mitochondrial serine/threonine-protein kinase PINK1 play a role in mitochondrial quality control. Using CRISPR/CAS9 technology we generated three human iPSC lines from the well characterized AIW002-02 control line. These isogenic iPSCs contain homozygous knockouts of PRKN (PRKN-KO, CBIGi001-A-1), PINK1 (PINK1-KO, CBIGi001-A-2) or both PINK1 and PRKN (PINK1-KO/PRKN-KO, CBIGi001-A-3). The knockout lines display normal karyotypes, express pluripotency markers and upon differentiation into relevant brain cells or midbrain organoids may be valuable tools to model Parkinson's disease.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] Generation of a FOXH1 homozygous knockout human embryonic stem cell line by CRISPR/Cas9 system
    Zhang, Tian
    Huang, Wanlan
    Xue, Xingkui
    STEM CELL RESEARCH, 2021, 50
  • [22] Generation of heterozygous and homozygous NF1 lines from human-induced pluripotent stem cells using CRISPR/Cas9 to investigate bone defects associated with neurofibromatosis type 1
    Darle, Annabelle
    Mahiet, Thibault
    Aubin, Deborah
    Doyen, Manon
    El Kassar, Lina
    Parfait, Beatrice
    Lemaitre, Gilles
    Baldeschi, Christine
    Allouche, Jennifer
    Holic, Nathalie
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2024, 12
  • [23] Generation of a PPP1CA knockout human pluripotent stem cell line via CRISPR/Cas9
    Wang, Xiaoman
    Sun, Jiaan
    Fu, Chong
    Liu, Chang
    STEM CELL RESEARCH, 2023, 69
  • [24] Generation of a FMR1 homozygous knockout human embryonic stem cell line (WAe009-A-16) by CRISPR/Cas9 editing
    Giri, Subhajit
    Purushottam, Meera
    Viswanath, Biju
    Muddashetty, Ravi S.
    STEM CELL RESEARCH, 2019, 39
  • [25] Gene editing and clonal isolation of human induced pluripotent stem cells using CRISPR/Cas9
    Yumlu, Saniye
    Stumm, Juergen
    Bashir, Sanum
    Dreyer, Anne-Kathrin
    Lisowski, Pawel
    Danner, Eric
    Kuehn, Ralf
    METHODS, 2017, 121 : 29 - 44
  • [26] Generation of two homozygous SHOX2 knock-out human induced pluripotent stem cell lines using CRISPR/Cas9
    Raedecke, Kristin
    Gore, Ambuj
    Burau, Karin
    Laugsch, Magdalena
    Koehler, Katrin
    Rappold, Gudrun A.
    Hoffmann, Sandra
    STEM CELL RESEARCH, 2023, 69
  • [27] Generation of a TMEM43 knockout human induced pluripotent stem cell line (HDZi003-A-1) using CRISPR/Cas9
    Ratnavadivel, Sandra
    Dammeier, Joline
    Gaertner, Anna
    de Toledo, Marcelo A. Szymanski
    Zenke, Martin
    Gummert, Jan
    Rasmussen, Torsten Bloch
    Klinke, Nora
    Juergens, Kai
    Meyer, Heiko
    Paululat, Achim
    Milting, Hendrik
    STEM CELL RESEARCH, 2024, 76
  • [28] Generation of a FTO gene knockout human embryonic stem cell line using CRISPR/Cas9 editing
    Wei, Cong
    Luo, Qian
    Wang, Binsheng
    Long, Yan
    Zhang, Meng
    Shan, Wei
    Yu, Xiaohong
    Xu, Yulin
    Qian, Pengxu
    Huang, He
    STEM CELL RESEARCH, 2021, 53
  • [29] Generation of two RNF2 homozygous knockout human embryonic stem cell lines by CRISPR/Cas9 system
    Shan, Yongli
    Ma, Lishi
    Zhang, Cong
    Zhang, Yanqi
    Zhang, Jingyuan
    Xiao, Lu
    Wei, Yanxing
    Yu, Yanhong
    STEM CELL RESEARCH, 2020, 47
  • [30] Derivation of Induced Pluripotent Stem Cells Line (RCPCMi009-A-1) with Knockout of the UBE2A Gene Using CRISPR/Cas9 Genome Editing
    E. A. Khomyakova
    A. V. Fedorenko
    A. V. Surdina
    E. A. Volovikov
    L. D. Belikova
    E. A. Zerkalenkova
    M. A. Lagarkova
    A. N. Bogomazova
    Russian Journal of Developmental Biology, 2023, 54 : 365 - 373